Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U8AS
|
|||
Former ID |
DNCL002514
|
|||
Drug Name |
Telapristone
|
|||
Synonyms |
Telapristone acetate; Proellex; 198414-31-2; UNII-1K9EYK92PQ; CDB-4124; 1K9EYK92PQ; Telapristone acetate [USAN]; Telapristone acetate (USAN); CCRIS 9331; CDB 4124; SCHEMBL374762; CHEMBL2105694; DTXSID60173587; RU-44675; 17alpha-Acetoxy-11beta-(4-(dimethylamino)phenyl)-21-methoxy-19-norpregna-4,9-dien-3,20-dione; D09972; 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-21-methoxy-, (11beta)-; A-Acetoxy-21-methoxy-11
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Endometriosis [ICD-11: GA10; ICD-10: N80, N80.9; ICD-9: 617] | Phase 2 | [1] | |
Company |
Repros Therapeutics
|
|||
Structure |
Download2D MOL |
|||
Formula |
C29H37NO4
|
|||
Canonical SMILES |
CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C(=O)COC)O)C5=CC=C(C=C5)N(C)C
|
|||
InChI |
1S/C29H37NO4/c1-28-16-24(18-5-8-20(9-6-18)30(2)3)27-22-12-10-21(31)15-19(22)7-11-23(27)25(28)13-14-29(28,33)26(32)17-34-4/h5-6,8-9,15,23-25,33H,7,10-14,16-17H2,1-4H3/t23-,24+,25-,28-,29-/m0/s1
|
|||
InChIKey |
BHERMCLNVOVDPU-DQFOBABISA-N
|
|||
CAS Number |
CAS 198414-30-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Progesterone receptor (PGR) | Target Info | Antagonist | [2] |
KEGG Pathway | Oocyte meiosis | |||
Progesterone-mediated oocyte maturation | ||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | |||
Reactome | Nuclear signaling by ERBB4 | |||
Nuclear Receptor transcription pathway | ||||
WikiPathways | Ovarian Infertility Genes | |||
Signaling by ERBB4 | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014404) | |||
REF 2 | In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone. J Steroid Biochem Mol Biol. 2004 Mar;88(3):277-88. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.